MediWound Ltd., was legally incorporated in Israel on January 27, 2000. The company is a global leader in next-generation enzyme therapies focused on non-surgical tissue repair. The company's solution selectively removes inactive and dangerous tissue while preserving healthy tissue, providing a safer and more effective alternative to traditional methods. With strong internal research, development and manufacturing capabilities, the company manufactures and commercializes cutting-edge biologics for wound and burn care that exceed existing standards of care, improve patient prognosis, and reduce healthcare costs by eliminating the need for surgical intervention. 

According to MediWound's 15-minute chart, there are several technical indicators that suggest a potential turnaround in the company's stock price. Specifically, the Relative Strength Index (RSI) has reached oversold levels, indicating that the stock price has fallen too rapidly and is likely due for a rebound. Additionally, the KDJ Golden Cross, which is a momentum indicator, has crossed above the 09/11/2026 13:00 level, suggesting that the momentum of the stock price is shifting towards the upside and has the potential to further increase. This combination of indicators suggests that MediWound's stock price is likely to rebound and potentially experience further gains in the near future.Several technical indicators on MediWound Ltd. (NASDAQ: MDWD) suggest a potential shift in the stock's momentum. The Relative Strength Index (RSI) has entered oversold territory, signaling that the stock may be due for <a href="https://www.google.com/goto?url=CAESaAHrOzAVBM9tvKZY7pFMdlmF2MtbtiUywRjuGdlqh2qcy6IBAqNEHsJosquYokiZrDamsdkenNNINO9HsRfv3nFvs8aG0Q7LJ9m9yyBj8uY6xXBIsJaWbQ98yxkudai_PSvg_jQ6bsxo">a short-term rebound</a> after a period of rapid price decline. This condition often precedes a reversal as traders may begin to anticipate a correction.Additionally, the KDJ Golden Cross, a momentum-based indicator, has crossed above the 09/11/2026 13:00 level, indicating <a href="https://www.google.com/goto?url=CAESdAHrOzAVmz7gjUmeRFVcu3uzEddVprJ0WvVOsW3TYdC1KFRSHWG-EJWqZJZoYp2K25e9juJSIL9RZNxrgz26tOZkWQ_gATgc0gfV_cAgRjYymWd4b3-a4-R_vCxrWuxPnHLt_ZbqnAoBFSkX2O__uz0VUmNX">a potential upward shift</a> in the stock's trajectory. This crossover is often interpreted as a sign of increasing bullish momentum and could suggest further gains in the near term.While these indicators point to a possible turnaround, investors should remain cautious and consider broader market conditions and fundamental factors before making investment decisions. Technical signals, while informative, do not guarantee future price movements and should be used in conjunction with other forms of analysis.

MediWound

MediWound's 15min chart sees RSI Oversold, KDJ Golden Cross signals.

MediWound's 15-minute chart has triggered a KDJ Death Cross and a Bearish Marubozu on September 11, 2026, at 12:15. This indicates a shift in momentum towards the downside, with a potential for further decreases in the stock price. Sellers are currently in control of the market, and bearish momentum is likely to persist.On September 11, 2026, at 12:15, MediWound’s 15-minute chart recorded a KDJ Death Cross and a Bearish Marubozu, signaling a potential shift in momentum toward the downside. The KDJ Death Cross occurs when the short-term moving average crosses below the long-term moving average, <a href="https://www.google.com/goto?url=CAESawHrOzAVRFnDFBQleO552YRV2uZ3Ow49Jp46UKY2Ewz0h83AwsGDQWW76gpPITCTQzG5HIIDhJ-rcGZyY9JP2m_GUda6cznm3ilPfvxZ1AdlOY_AMzp1yeBPetSvtuB1l8iGongz0y7pArue">historically associated with bearish trends</a>. This event, combined with the Bearish Marubozu—a candlestick pattern indicating strong selling pressure—suggests that <a href="https://www.google.com/goto?url=CAESawHrOzAVRFnDFBQleO552YRV2uZ3Ow49Jp46UKY2Ewz0h83AwsGDQWW76gpPITCTQzG5HIIDhJ-rcGZyY9JP2m_GUda6cznm3ilPfvxZ1AdlOY_AMzp1yeBPetSvtuB1l8iGongz0y7pArue">sellers are in control</a>.While the death cross is often interpreted as a bearish signal, historical data indicates that it does not always precede a prolonged downturn. In some instances, it has <a href="https://www.google.com/goto?url=CAESawHrOzAVRFnDFBQleO552YRV2uZ3Ow49Jp46UKY2Ewz0h83AwsGDQWW76gpPITCTQzG5HIIDhJ-rcGZyY9JP2m_GUda6cznm3ilPfvxZ1AdlOY_AMzp1yeBPetSvtuB1l8iGongz0y7pArue">coincided with short-term corrections</a> followed by market rebounds. However, when the death cross occurs after significant market losses, it may <a href="https://www.google.com/goto?url=CAESawHrOzAVRFnDFBQleO552YRV2uZ3Ow49Jp46UKY2Ewz0h83AwsGDQWW76gpPITCTQzG5HIIDhJ-rcGZyY9JP2m_GUda6cznm3ilPfvxZ1AdlOY_AMzp1yeBPetSvtuB1l8iGongz0y7pArue">reflect deteriorating fundamentals</a> and downward momentum.The Bearish Marubozu further reinforces the bearish sentiment, as it typically signals a lack of buying interest and continued downward pressure. Traders and investors should remain cautious, as these patterns may indicate a continuation of the current downward trend. As always, it is important to consider broader market conditions and additional technical indicators before making investment decisions.

MediWound's 15min chart signals bearish trend with KDJ Death Cross and Bearish Marubozu.

MediWound CEO Ofer Gonen will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference. The event will take place September 14-16, 2026, at the Lotte New York Palace Hotel. The fireside chat, moderated by Swayampakula Ramakanth, will be available via live webcast on MediWound's website. MediWound is a global biotechnology company developing enzymatic therapies for tissue repair, with a focus on burns and chronic wounds.

MediWound to Present at H.C. Wainwright Global Investment Conference

Mediwound Ltd. (MDWD) shares have entered oversold territory with an RSI reading of 28.3, after falling to $12.61 per share. The S&P 500 ETF's RSI reading is 53.4. A bullish investor could see this as an exhaustion of heavy selling and look for entry points on the buy side. MDWD's 52-week low is $12.61, with a high of $20.30 and a last trade of $12.70.

Mediwound Stock Dips to Oversold Territory Amid Heavy Selling.

Oppenheimer Downgrades MediWound to Outperform with PT of $30 from $32

MDWD News